Efficacy data?, page-19

You have confused me with this statement,,"We can also be very sure that the drug was not a miracle cure at these doses or the trial would have been halted for ethical reasons"
if you are able can you elaborate ? as in my experience when you see remarkable results the DSMB can accelerate the testing to Trial Participants in a commercial sense paying for trial treatment.
I'm in one Biotech where the trial patients doctors requested the Patients stay on the trial drug even after testing was completed because the benefit was so great...